Dube Eric M Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
28
Insider Sells Sum
$5.28M

Insider Activity of Dube Eric M

According to the SEC Form 4 filings, Dube Eric M, being in a position of

  1. CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1010322 shares for $50.82M,
    over all time since 2020-01-07, has bought 0 shares, and sold 1393081 share for $59.74M.

Biography of Dube Eric M

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $50,823,30511100

Comparison of Insiders on Amount of Buys and Sells

2026-10-15SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
243,735
0.2636%
$53.82$13.12M-4.36%
2026-09-17SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
108,493
0.1164%
$64.61$7.01M-18.78%
2026-09-16SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
195,841
0.2105%
$63.45$12.43M-17.01%
2026-09-15SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
95,666
0.1025%
$62.26$5.96M-15.55%
2026-05-06SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
22,500
0.0237%
$43.95$988,875+25.87%
2026-04-15SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
64,000
0.0907%
$41.09$2.63M+36.08%
2026-04-01SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
60,000
0.064%
$30.93$1.86M+75.4%
2026-02-20SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
60,000
0.0664%
$30.10$1.81M+71.17%
2026-02-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
100,087
0.1099%
$32.28$3.23M+53.44%
2026-01-27SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
51,865
0.0581%
$30.10$1.56M+65.78%
2026-01-23SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
8,135
0.0093%
$30.01$244,153+68.16%
2025-10-29SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
27,128
0.0326%
$30.12$817,074+40.96%
2025-10-28SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
92,872
0.1124%
$30.38$2.82M+41.33%
2025-05-05SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
18,924
0.021%
$21.05$398,350+29.47%
2025-02-11SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
11,375
0.0149%
$24.04$273,455-11.2%
2025-02-03SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
50,691
0.0575%
$20.21$1.02M+4.3%
2025-01-22SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
10,736
0.0125%
$19.46$208,923+6.94%
2024-09-09SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
21,125
0.0247%
$11.52$243,360+37.44%
2024-02-01SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
19,122
0.0247%
$8.70$166,435+5.29%
2024-01-23SaleTravere Therapeutics, Inc.
TVTX
CHIEF EXECUTIVE OFFICER
7,873
0.0101%
$8.96$70,542-3.12%
Total: 41
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.